Ovarian cancer cells, which commonly have a loss of expression of the PI3K pathway regulator PTEN, when treated with a PI3K inhibitor called D-116883, exhibit an increase in apoptosis and a decrease in cell growth [17]. Here, PIK3CA is linked to ovarian carcinoma.